DSpace at RU >

Browsing by Author Lokhorst, H.M.

Full Text	Issue Date	Title	Author(s)
	2011	Diagnostiek bij multipel myeloom: de rol van beeldvorming, chromosomenanalyse en multiparameterflowcytometrie.	Zweegman, S.; Minnema, M.C.; Stevens-Kroef, M.J.P.L.; Kersten, M.J.; Wijermans, P., et al
	2010	A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.	Lokhorst, H.M.; Holt, B. van der; Zweegman, S.; Vellenga, E.; Croockewit, S., et al
	2008	Sporadic late-onset nemaline myopathy effectively treated by melphalan and stem cell transplant.	Voermans, N.C.; Minnema, M.; Lammens, M.M.Y.; Schelhaas, H.J.; Kooi, A.V., et al
	2008	Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome.	Minnema, M.C.; Donk, N.W. van de; Zweegman, S.; Hegenbart, U.; Schonland, S., et al
	2008	High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.	Lokhorst, H.M.; Hazenberg, B.P.C.; Croockewit, A.
	2008	Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis.	Spaapen, R.M.; Lokhorst, H.M.; Oudenalder, K. van den; Otterud, B.E.; Dolstra, H., et al
	2008	Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.	Lokhorst, H.M.; Schmidt-Wolf, I.; Sonneveld, P.; Holt, B. van der; Martin, H., et al
	2007	A 'muscle' man without exercise: muscle pseudohypertrophy in myeloma-associated generalized amyloidosis.	Sibelt, L.A.G.; Lokhorst, H.M.; Kerkhof, P.C.M. van de; Dooren-Greebe, R.J. van
	2007	Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma : long-term follow-up of the Dutch Cooperative Group HOVON 24 trial	Sonneveld, P.; Holt, B. van der; Segeren, C.M.; Vellenga, E.; Croockewit, A.J., et al
	2006	Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.	Donk, N.W. van de; Kroger, N.; Hegenbart, U.; Corradini, P.; San Miguel, J., et al
	2006	Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma.	Donk, N.W. van de; Kroger, N.; Hegenbart, U.; Corradini, P.; San Miguel, J., et al
	2004	The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma.	Lokhorst, H.M.; Wu, K.; Verdonck, L.F.; Laterveer, L.; Donk, N.W. van de, et al
	1997	Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation	Lokhorst, H.M.; Schattenberg, A.V.M.B.; Cornelissen, J.J.L.M.; Thomas, L.L.M.; Verdonck, L.F.